TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Carls-Bergh Pharma AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,924
|
2,007
|
2,457 |
| Financial expenses |
2
|
4
|
2 |
| Earnings before taxes |
-93
|
14
|
401 |
| EBITDA |
-66
|
53
|
434 |
| Total assets |
2,352
|
2,244
|
2,215 |
| Current assets |
1,328
|
1,205
|
1,104 |
| Current liabilities |
601
|
387
|
320 |
| Equity capital |
1,467
|
1,457
|
1,575 |
| - share capital |
18
|
18
|
20 |
| Employees (average) |
12
|
14
|
14 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
62.4%
|
64.9%
|
71.1% |
| Turnover per employee |
160
|
143
|
176 |
| Profit as a percentage of turnover |
-4.8%
|
0.7%
|
16.3% |
| Return on assets (ROA) |
-3.9%
|
0.8%
|
18.2% |
| Current ratio |
221.0%
|
311.4%
|
345.0% |
| Return on equity (ROE) |
-6.3%
|
1.0%
|
25.5% |
| Change turnover |
-89
|
-251
|
307 |
| Change turnover % |
-4%
|
-11%
|
14% |
| Chg. No. of employees |
-2
|
0
|
0 |
| Chg. No. of employees % |
-14%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.